Article

Advisory Group Issues Consensus Recommendations for Neuro-Behçet's Disease

Author(s):

Agreed-upon guidelines include Neuro-Behçet's disease (NBD) diagnostic criteria and recommendations on when to consider NBD in a neurological patient.

Though it is a relatively uncommon condition, Neuro-Behçet’s disease (NBD) is a serious manifestation of Behcet’s disease that neurologists must consider in their differential diagnoses of inflammatory, infective, or demyelinating central nervous system disorders. However, evidence-based information on NBD diagnosis and management is scarce, and planning for such studies is challenging.

On behalf of the International Neuro-Behçet’s Advisory Group, Seema Kaira, MD, and colleagues developed expert consensus recommendations using an extensive literature review and wide consultations with an international advisory panel, followed by a Delphi exercise.

The agreed-upon guidelines — which were published online December 24, 2013, in the Journal of Neurology — include NBD diagnostic criteria with 2 levels of certainty and recommendations on when to consider NBD in a neurological patient, as well as on the use of various paraclinical tests. Management recommendations include the treatment of parenchymal NBD and cerebral venous thrombosis, the use of disease-modifying therapies, prognostic factors, and outcome measures.

Related Videos
The APAC Recap: Peripheral Artery Disease at CAPP Live 2024 with Bob Ross, PA-C | Image Credit: APAC
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
© 2024 MJH Life Sciences

All rights reserved.